“…This is a cost-effective and time-efficient approach that translates into a rapid turnaround of results which is vital to accelerating process development and manufacturing of new drug substances. Some examples include the analysis of solvents and volatile amines by gas chromatography (GC), ,,,, a generic method for nucleotides and palladium scavengers by ion exchange chromatography (IEC), dehalogenation impurities and mixtures of halogen isomers, ,− drug metabolites and analogues, − direct analysis of chiral active pharmaceutical ingredients (APIs) and their counterions by UHPLC, enantiopurity analysis across an entire synthetic route using a single chiral core–shell column in LC mode, generic chiral method development in SFC, and synthetic intermediates containing multiple stereocenters by two-dimensional LC, among others …”